GWM
RXII

Gupta Wealth Management’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Gupta Wealth Management’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-400
Closed -$1K – 1416
2015
Q2 		$1K Hold
400
– – ﹤0.01% 1239
2015
Q1 		$1K Buy
+400
New +$1K ﹤0.01% 1143

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Gupta Wealth Management's RXII Position: Q3 2015 in Review

Gupta Wealth Management sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 400 shares — an estimated $1K sold.

Gupta Wealth Management first reported a position in RXII in Q1 2015 and held it in 2 quarters. The position peaked at $1K in Q2 2015. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

  • Gupta Wealth Management reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
  • Gupta Wealth Management sold 400 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $1K.
  • Gupta Wealth Management first reported a position in GALENA BIOPHARMA INC COM in Q1 2015 and held it in 2 quarters.
  • Gupta Wealth Management's GALENA BIOPHARMA INC COM position peaked at $1K in Q2 2015.
  • 78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Gupta Wealth Management's 13F filing for Q3 2015, filed 18 Nov 2015.